Login / Signup

Continuation of aspirin therapy before pars plana vitrectomy: Safe or not?

Jin WangQingjian LiYu ZhangXin CheJing JiangYiwen QianZhiliang Wang
Published in: European journal of ophthalmology (2020)
The outcomes of our study indicate that PPV under retrobulbar anesthesia can be safely performed without discontinuing systemic aspirin therapy.
Keyphrases
  • low dose
  • cardiovascular events
  • antiplatelet therapy
  • diabetic retinopathy
  • cardiovascular disease
  • stem cells
  • type diabetes
  • mesenchymal stem cells
  • weight loss
  • drug induced